Currently predicting for Mon, 22 Jul 2024

Trading levels for QURE

Fibonacci Support & Resistance Levels

Level Price
R3 8.12 4.91%
R2 7.98 3.13%
R1 7.90 2.04%
Price 7.74
S1 7.62 -1.52%
S2 7.54 -2.62%
S3 7.40 -4.39%

Accumulated Volume Support & Resistance Levels

Level Price
R3 9.11 17.70%
R2 8.91 15.12%
R1 8.72 12.66%
Price 7.74
S1 6.67 -13.82%
S2 0 -
S3 0 -

QURE Predictions History

7 months ago
ramim66809.408994 predicted that QURE for 2023-12-21 is going

Rank:

4 years ago
StockVader predicted that QURE for 2019-12-05 is going

4 years ago
PumpTheseNumbers predicted that QURE for 2019-12-05 is going $63.09 (-2.31%)

4 years ago
JS predicted that QURE for 2019-12-05 is going $66.07 (2.31%)

4 years ago
Irmantas Bačiulis predicted that QURE for 2019-12-05 is going

Rank:

4 years ago
RobertJordan129117 predicted that QURE for 2019-12-05 is going $64.00 (-2.11%)

Rank:

5 years ago
joe1234 predicted that QURE for 2019-05-13 is going $62.92 (9.08%)

5 years ago
NameNotImportant predicted that QURE for 2019-05-06 is going $58.76 (0.03%)

5 years ago
NameNotImportant predicted that QURE for 2019-05-03 is going $61.84 (5.28%)

5 years ago
NameNotImportant predicted that QURE for 2019-04-29 is going $58.76 (3.74%)

Click to get the best stock tips daily for free!

About uniQure N.V.

uniQure N.V. uniQure N.V., a gene therapy company, engages in the development of treatments for patients suffering from genetic and other devastating diseases. Its lead program is Etranacogene dezaparvovec (AMT-061), which is in Phase III HOPE-B pivotal trial for the treatment of hemophilia B. The company also engages in developing AMT-130, a gene therapy that is in Phase I/II clinical study for the treatment of Huntington's disease; AMT-060, which is in Phas... QURE Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT